Reshaping Addiction Recovery with Human-Centered Harm Reduction
The Opioid Matrix: A Journey Into the Rabbit HoleShow Notes
Opioid addiction isn’t just about the drug—the problem is usually much deeper. Addressing the crisis and waging a war on fentanyl will not be successful until those on the frontlines start treating people who suffer from addiction as humans.
In this episode, we’re joined by CJ Syas and Adam Tripp of Mantra Recovery. Having struggled with opioid addiction themselves, CJ and Adam joined together to work together, one-on-one with people facing addiction to provide resources, guidance and recovery support. According to them, the missing piece of the puzzle is harm reduction and professional intervention.
Join us as we discuss: Necessary resources and support for overcoming addiction Striking a balance between helping people, enabling addiction and keeping communities healthy and safe Addiction, mental health and the unique needs of underserved communities
To make sure you never miss an episode of The Opioid Matrix, subscribe on Apple Podcasts, Spotify, the website, or your favorite podcast player. Listening on a desktop & can’t see the links? Just search for The Opioid Matrix in your favorite podcast player.
More from The Opioid Matrix: A Journey Into the Rabbit Hole
Is the fentanyl crisis simply a drug epidemic—or something far more strategic?
In this episode of The Opioid Matrix, host Michael Brown speaks with Ralph Ornelas, a 36-year veteran of the Los Angeles County Sheriff’s Department, about the domestic networks helping fuel America’s fentanyl crisis.
In this episode of The Opioid Matrix, Michael Brown speaks with Adam Castillo, a former U.S. Marine officer, founder of AGS Myanmar, and former president of the American business community in Myanmar. Adam is also the author of Finding Our Voice: A Story of Leadership in Crisis and the American Spirit Abroad, a leadership memoir shaped by his experience guiding an American business community through Myanmar’s post-coup collapse.
What happens when a fully synthetic drug turns organized crime into an industrial-scale, cross-border killing machine?
What happens when the world’s most dangerous networks evolve faster than the systems meant to stop them?